Purchase Order HHSN272201800290P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $17,478.36 on November 7, 2018, for HotStartAQ Plus DNA Polymerase (catalog number 203609, quantity 25,000 units) under firm fixed-price pricing. Work is performed in Valencia, California. The order is not set-aside and carries an ultimate completion date of November 25, 2018.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for Hot Star Plus DNA Polymerase (25,000 units) with a ceiling value of $12,237.36 on July 16, 2019. Place of performance is Bethesda, Maryland. Ultimate completion date is August 1, 2019. The order is firm fixed price with no set-aside applied.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,044.72 firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The order is for 2 kits of HOTSTARTAQ DNA POLYMERASE (25000). There is no set-aside designation noted. Qiagen has provided a range of products and services to various federal agencies, including DNA/RNA extraction kits, next-generation sequencing,...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for RNA and DNA screening kits valued at $4,491.12 on August 24, 2017, with an ultimate completion date of August 31, 2017. The order carries firm fixed pricing and no set-aside designation. Place of performance is Valencia, California.</p>

The U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $17,677.70 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The order is for HOTSTARTAQ PLUS DNA POLYMERASE and does not have a set-aside designation. Qiagen, which has provided a range of molecular diagnostics, genomics, and bioinformatics products and services to federal agencies, is...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $140,902.60 firm fixed-price purchase order to Qiagen, LLC to provide 310 kits of HotstarTaq Plus DNA Polymerase. This specialized reagent is used in polymerase chain reaction assays to detect and sequence B cell receptor DNA from human lymphocytes involved in immune responses against HIV and other infectious diseases. The contract has a performance period of...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $12,928.46 on August 15, 2017, for RNA kits, beads, and processor equipment on a firm fixed price basis. Work is performed in Hamilton, Montana, with an ultimate completion date of September 1, 2017.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for RNA, PCR, and plasmid kits valued at $13,517.30 on June 21, 2017, with ultimate completion on June 26, 2017. Place of performance is Hamilton, Montana. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for DNA polymerase with a ceiling value of $35,250.56 on February 8, 2018, with ultimate completion on February 14, 2019. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $10,736.64 on August 11, 2020. The order covers ten HISPEED Plasmid Maxi Kits at $252.00 each, priced on a firm fixed-price basis. Work is performed in Germantown, Maryland, with an ultimate completion date of September 6, 2020. No small business set-aside applies.</p>